v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock (Class A, B and Exchangeable)
Additional Paid-in-Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024   396,802,394      
Beginning balance at Dec. 31, 2024 $ 1,034,782 $ 4 $ 2,473,698 $ (1,431,283) $ (7,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (202,487)     (202,487)  
Other comprehensive income (loss) 21,782       21,782
Stock option exercises and other (in shares)   4,108,659      
Stock option exercises and other 2,788   2,712 76  
Stock-based compensation 36,058   36,058    
Common stock sales issuances, net of issuance costs (in shares)   5,499,680      
Common stock sales issuances, net of issuance costs 41,024   41,024    
Ending balance (in shares) at Mar. 31, 2025   406,410,733      
Ending balance at Mar. 31, 2025 $ 933,947 $ 4 2,553,492 (1,633,694) 14,145
Beginning balance (in shares) at Dec. 31, 2025 528,182,693 528,182,693      
Beginning balance at Dec. 31, 2025 $ 1,130,865 $ 5 3,170,145 (2,076,002) 36,717
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (117,504)     (117,504)  
Other comprehensive income (loss) (10,055)       (10,055)
Stock option exercises and other (in shares)   2,613,410      
Stock option exercises and other (752)   (752)    
Stock-based compensation $ 22,215   22,215    
Ending balance (in shares) at Mar. 31, 2026 530,628,653 530,796,103      
Ending balance at Mar. 31, 2026 $ 1,024,769 $ 5 $ 3,191,608 $ (2,193,506) $ 26,662